Autoantibody against WD repeat domain 1 is a novel serological biomarker for screening of thyroid neoplasia
- 6 December 2012
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 79 (1), 35-42
- https://doi.org/10.1111/cen.12121
Abstract
Background Thyroid nodules are common among adults, and accurate diagnosis is critical in for management decisions. Ultrasound and fine needle aspiration cytology are the most common methods to evaluate nodules, but they are not practical for screening large numbers of patients because of cost and time considerations. Objective The aim of this study was to isolate an autoantibody to tumour antigen, WD repeat domain 1 (WDR1), and evaluate its diagnostic sensitivity and specificity for thyroid neoplasms. Patients and Methods We investigated serological biomarkers in patients with thyroid carcinoma who had a poor prognosis. Using a serological analysis of recombinant cDNA expression cloning (SEREX) strategy, we isolated WDR1 and its specific autoantibody in the sera of patients with undifferentiated thyroid carcinoma (UTC). We examined using indirect ELISA, the titre of the anti‐WDR1 antibody (AWA) in 54 study patients: 10 with UTC, 20 with papillary thyroid carcinoma (PTC), 17 with benign thyroid nodule (BTN), 7 with autoimmune thyroid disease (AITD), as well as 38 controls (N). Results WDR1 was ubiquitously expressed in various types of thyroid tissues. However, the titre of AWA in UTC and PTC was significantly higher than that in BTN, AITD and N (P < 0·001). No significant correlation was observed between thyroid function, serum thyroglobulin and tumour diameter. The cut‐off value estimated using ROC to differentiate malignancies from others was 0·95 (sensitivity 96·7%, specificity 91·9%, AUC 0·969, P < 0·001). Conclusions Anti‐WDR1 antibody could be a novel approach for serological screening of PTC and UTC, and could be an efficient and inexpensive biomarker.Keywords
This publication has 31 references indexed in Scilit:
- Epidemiological studies of Fukushima residents exposed to ionising radiation from the Fukushima Daiichi Nuclear Power Plant prefecture—a preliminary review of current plansJournal of Radiological Protection, 2012
- Tumour auto-antibody screening: performance of protein microarrays using SEREX derived antigensBMC Cancer, 2010
- A systematic review of humoral immune responses against tumor antigensCancer Immunology, Immunotherapy, 2009
- Molecular Testing for Mutations in Improving the Fine-Needle Aspiration Diagnosis of Thyroid NodulesJournal of Clinical Endocrinology & Metabolism, 2009
- Approach to the Patient with a Cytologically Indeterminate Thyroid NoduleJournal of Clinical Endocrinology & Metabolism, 2008
- Mutations in the cofilin partner Aip1/Wdr1 cause autoinflammatory disease and macrothrombocytopeniaBlood, 2007
- Increasing Incidence of Thyroid Cancer in the United States, 1973-2002JAMA, 2006
- Detection of the novel autoantibody (anti-UACA antibody) in patients with Graves’ diseaseBiochemical and Biophysical Research Communications, 2004
- Identification of a Novel Autoantigen UACA in Patients with PanuveitisBiochemical and Biophysical Research Communications, 2001
- Iodide Suppression of Major Histocompatibility Class I Gene Expression in Thyroid Cells Involves Enhancer A and the Transcription Factor NF- BMolecular Endocrinology, 1997